Medication Use Behavior and Health Outcomes of Type 2 Diabetes Health Care in Occupied Palestine
Publication Type
Conference Paper
Authors
  •  

 The prevalence of Type 2 diabetes mellitus (DM2) patients has increased rapidly worldwide, especially in Middle East Countries. In Occupied Palestine Territories (OPT), there were problems in health care of DM2 in OPT, such as lifestyle, inappropriate perspectives and medication use and lack of research related to health care. The present study aimed to identify the medication behaviours and outcomes among DM2 patients in OPT. The study was an observational retrospective study. Data from 330 DM2 patients were collected from National Centre of Chronic Diseases and Dermatology in Ramallah from November 2012 through November 2013. More than half of the participants were male (51.2%, N = 169; female: 48.8%, N = 161). Sixty nine of the participants were low income patients. Two hundred seven (62.73%) participants had been diagnosed with DM2 for more than ten years. One participant was under diet control without any antidiabetic medications. Seventy four (22.4%) participants received only Insulin injections, and seventy four (22.4%) participants were receiving only oral hypoglycemic medications. More than half of the participants (N=181, 54.8%) received combined oral Insulin injection medications The mean and median numbers of total medications per day were 6.3848 (SD = 2.9) and 6, respectively. HbA1c testing was not measured for fifty nine participants (17.87%). Based on WHO medical standards of diabetes care, only 4.43% of the participants who have been pursuing their HbA1c levels was well controlled (i.e. optimal control: HbA1c<6%). The control of almost forty one percent of them (40.96%, N = 111) were acceptable but need improvement (HbA1c 6%–8%), and 54.61% (n=148) were in poor control and needed intensive treatment (HbA1c>8%) and intervention. Although there were some positive signs in some of the factors, DM2 care management in OPT was relatively poor. Various interventions from health care professionals should be developed to improve the quality of healthcare services for DM2 patients in OPT

Conference
Conference Title
Fourth International Conference on Pharmaceutical, Nutraceuticals, and Cosmetic Science (IPNaCS) 2015, MARA University of Technology (UiTM)
Conference Country
Malaysia
Conference Date
Nov. 12, 2015 - Nov. 13, 2015
Conference Sponsor
MARA University of Technology. Malaysia
Additional Info
Conference Website